Jim McCarthy Named as Thredd CEO
Incumbent Kevin Schultz to retire after transition period Jim McCarthy joined Thredd in January 2023…
2 years ago
Wire Stories
Renesas Announces New Organizational Structure to Accelerate Next Phase of Growth
TOKYO--(BUSINESS WIRE)--#Renesas--Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced…
2 years ago
Alipay Enhances Accessible Payment Service in Support of Asian Para Games
HANGZHOU, China--(BUSINESS WIRE)--As part of Ant Group’s “Asian Para Games Support Initiative,†Alipay, the leading…
2 years ago
Reltio Names Vidhi Chugh as Head of Product Management for AI/ML Solutions
Acclaimed AI ethicist and data governance expert on board to further expand Reltio’s innovation BENGALURU,…
2 years ago
Syncell Appoints Life Science Industry Leaders Dr. Martin Madaus and Dr. Don Kania as Business Strategic Advisors
Dr. Martin Madaus and Dr. Don Kania are recognized for their significant contributions to the…
2 years ago
Vaccine Journal Highlights the Potential for Self-Administration of Vaccines Using Vaxxas High-Density Microarray Patch (HD-MAP)
Self-administration of vaccines using the Vaxxas high-density microarray patch (HD-MAP) could reduce the need for…
2 years ago
Triton Digital Releases the New Zealand Podcast Ranker for September 2023
AUCKLAND, New Zealand--(BUSINESS WIRE)--Triton Digital®, the global technology and services leader to the digital audio,…
2 years ago
Newmont CEO’s Statement on Pending Acquisition of Newcrest Achieving Legal Effectiveness in Australia
DENVER--(BUSINESS WIRE)--Newmont Corporation’s (NYSE: NEM, TSX: NGT) President and Chief Executive Officer, Tom Palmer, today…
2 years ago
Allison Transmission Selected for Australian Armored Vehicle Project as Part of Hanwha’s Redback
Australia’s Infantry Fighting Vehicle acquisition project winner is powered by Allison’s X1100-5A3â„¢ cross-drive transmission. INDIANAPOLIS--(BUSINESS…
2 years ago
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
Approval Based on Updated Positive Overall Survival Results from the Phase 3 ECHELON-1 Study for…
2 years ago